VBI Vaccines
VBIV
#10524
Rank
HK$14.57 M
Marketcap
HK$0.51
Share price
0.00%
Change (1 day)
-89.28%
Change (1 year)

EPS for VBI Vaccines (VBIV)

EPS in 2024 (TTM): -HK$79.49

According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -HK$78.90. In 2022 the company made an earnings per share (EPS) of -HK$102.70 a decrease over its 2021 EPS that were of -HK$63.02.

EPS history for VBI Vaccines from 1997 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-HK$79.49
2022-HK$102.7062.96%
2021-HK$63.0228.57%
2020-HK$49.02-54.35%
2019-HK$107.37-52.58%
2018-HK$226.4210.23%
2017-HK$205.4114.29%
2016-HK$179.73-62.8%
2015-HK$483.1790.68%
2014-HK$253.40-7.95%
2013-HK$275.30-57.97%
2012-HK$655.07-78%
2011-HK$2,9783151.47%
2010-HK$91.5923.87%
2009-HK$73.94-18.48%
2008-HK$90.7112.08%
2007-HK$80.94-49.47%
2006-HK$160.18
2005N/A-100%
2004-HK$71.2111.94%
2003-HK$63.61-81.89%
2002-HK$351.25196.44%
2001-HK$118.4984.33%
2000-HK$64.28-65.37%
1999-HK$185.62-29.45%
1998-HK$263.1029.61%
1997-HK$202.99

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Onconova Therapeutics
ONTX
-HK$7.39-90.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-HK$33.69-57.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
-HK$28.55-63.81%๐Ÿ‡บ๐Ÿ‡ธ USA